{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:05:20Z","timestamp":1794413120107,"version":"4.9.1"},"reference-count":49,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T00:00:00Z","timestamp":1255046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aims:\u2002<\/jats:bold>  <jats:italic>Plasmodium falciparum<\/jats:italic> (PF) infection can lead to severe complications. Ursodeoxycholic acid (UDCA) is increasingly used for the treatment of cholestatic liver diseases. The present study aims to determine the effects of combined UDCA and artesunate compared to placebo and artesunate on the improvement of liver tests in severe PF jaundiced patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> All severe PF jaundiced patients, aged \u2265\u200315\u2003years and diagnosed as having severe malaria according to WHO 2000 criteria, were enrolled. Patients with evidence of biliary obstruction, other cholestatic liver diseases and those who were pregnant were excluded. Patients were randomized to receive either oral UDCA or placebo for 2\u2003weeks in additional to artesunate. All patients were admitted for at least 14\u2003days to monitor the result of the treatment.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Seventy\u2010four severe PF malaria patients with jaundice were enrolled. Both groups had similar demographic and laboratory tests, with the exception being more males in the UDCA group than in the placebo group (<jats:italic>P<\/jats:italic>\u2003=\u20030.04). The median of percentage change of total bilirubin and aminotransferase levels at the end of weeks 1, 2, 3 and 4 showed no difference between the two groups. Only the median of percentage change of alkaline phosphatase at the end of week one compared with the baseline values showed less increment in the UDCA group than in the placebo group (<jats:italic>P<\/jats:italic>\u2003=\u20030.04). No serious adverse events were seen during the 4\u2003weeks of follow up.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> In severe PF malaria patients with jaundice, combined therapy with UDCA and artesunate is safe, but does not significantly improve liver tests compared to placebo and artesunate.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2009.06007.x","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T08:26:13Z","timestamp":1255076773000},"page":"362-368","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice"],"prefix":"10.1111","volume":"25","author":[{"given":"Sombat","family":"Treeprasertsuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udomsak","family":"Silachamroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivicha","family":"Krudsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Huntrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plengsakoon","family":"Suwannakudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suparp","family":"Vannaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polrat","family":"Wilairatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90363-J"},{"key":"e_1_2_6_3_2","first-page":"628","article-title":"Guideline in management of severe malaria","volume":"98","author":"Wilairatana P","year":"2000","journal-title":"J. Indian Med. Assoc."},{"key":"e_1_2_6_4_2","first-page":"355","article-title":"Consensus recommendation on the treatment of malaria in Southeast Asia","volume":"29","author":"Looareesuwan S","year":"1998","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67176-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/375059"},{"key":"e_1_2_6_7_2","first-page":"167","article-title":"Hepatic changes in P. falciparum malaria","volume":"29","author":"Mishra SK","year":"1992","journal-title":"Indian J. Malariol."},{"key":"e_1_2_6_8_2","first-page":"298","article-title":"Liver profile changes and complications in jaundiced patients with falciparum malaria","volume":"45","author":"Wilairatana P","year":"1994","journal-title":"Trop. Med. Parasitol."},{"key":"e_1_2_6_9_2","first-page":"59","article-title":"Malarial hepatitis: a heterogeneous syndrome?","volume":"5","author":"Anand AC","year":"1992","journal-title":"Natl. Med. J. India"},{"key":"e_1_2_6_10_2","first-page":"207","article-title":"Jaundice and hepatomegaly in primary malaria","volume":"79","author":"Ramachandran S","year":"1976","journal-title":"J. Trop. Med. Hyg."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg091"},{"key":"e_1_2_6_12_2","first-page":"101","article-title":"Falciparum malaria complicating cholestatic jaundice and acute renal failure","volume":"42","author":"Dash SC","year":"1994","journal-title":"J. Assoc. Physicians India"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.65.828"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0310057X9602400213","article-title":"Predictors of mortality in severe malaria: a two year experience in a non\u2010endemic area","volume":"24","author":"Blumberg L","year":"1996","journal-title":"Anaesth. Intensive Care"},{"key":"e_1_2_6_15_2","first-page":"172","article-title":"Falciparum malaria with acute liver failure","volume":"17","author":"Srivastava A","year":"1996","journal-title":"Trop. Gastroenterol."},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/archinte.1972.03650040130012","article-title":"Bile acids, liver injury, and liver disease","volume":"130","author":"Palmer RH","year":"1972","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36088"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260216"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70183-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012030-00017"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200006000-00014"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00243-5"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00592.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(00)90300-6"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1179\/000349804225021389"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.58.348"},{"key":"e_1_2_6_27_2","first-page":"37","article-title":"N\u2010acetylcysteine in severe falciparum malaria in Thailand","volume":"34","author":"Treeprasertsuk S","year":"2003","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/95.5.285"},{"key":"e_1_2_6_29_2","first-page":"616","article-title":"Jaundice in falciparum malaria; changing trends in clinical presentation\u2014a need for awareness","volume":"58","author":"Ahsan T","year":"2008","journal-title":"J. Pak. Med. Assoc."},{"key":"e_1_2_6_30_2","first-page":"247","article-title":"Malarial hepatitis as a component of multiorgan failure\u2014a bad prognostic sign","volume":"105","author":"Das SN","year":"2007","journal-title":"J. Indian Med. Assoc."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.779"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-007-0742-1"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703063361003"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.12.023"},{"key":"e_1_2_6_35_2","first-page":"184","article-title":"Nephropathy in leptospirosis","volume":"51","author":"Visith S","year":"2005","journal-title":"J. Postgrad. Med."},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0326"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0695"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000070043"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1973.tb119700.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000169042"},{"key":"e_1_2_6_41_2","first-page":"482","article-title":"Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure","volume":"9","author":"Tse KC","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01715.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00305.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199904000-00013"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-004-0032-2"},{"key":"e_1_2_6_46_2","first-page":"371","article-title":"Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin","volume":"130","author":"Poupon RY","year":"1979","journal-title":"Ann. Med. Interne (Paris)"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.009"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i7.1125"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322521"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.08.071"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2009.06007.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2009.06007.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:52:45Z","timestamp":1697320365000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2009.06007.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,28]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1440-1746.2009.06007.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2009.06007.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,28]]},"assertion":[{"value":"2010-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}